Abstract
Background: Flow‐mediated vasodilation (FMD) of the brachial artery (BA) has been shown to improve in response to lipid‐lowering therapy and other therapeutic interventions, usually within 1 to 2 months. Whether FMD remains improved under therapy in the longer term is unknown.
Hypothesis: The aim of this study was to examine the short‐and long‐term changes of FMD under statin therapy.
Methods: Flow‐mediated vasodilation and nitroglycerin‐mediated vasodilation (NMD) of the BA were measured with high‐resolution ultrasound (13 MHz) at baseline and at 4 and 10 months in 18 consecutively recruited patients with coronary artery disease (CAD), in whom statin therapy was newly established.
Results: The decrease of total plasma cholesterol levels after4 and 10 months of statin therapy (243 ± 31 vs. 186 ± 30 vs. 191 ± 40 mg/dl; p < 0.001) was accompanied by an increase in FMD from 4.4 ± 3.8% at baseline to 9.6 ± 2.7% at 4 months and to 9.5 ± 2.6%at 10 months (p < 0.001). Nitroglycerin‐mediated vasodilation showed a trend toward improvement after 4 months (14.6 ± 7.5 vs. 19.1 ± 3.6 vs. 19.4 ± 5.6%; NS). The FMD/NMD ratio also rose significantly after 4 months and remained improved after 10 months of statin therapy (0.31 ± 0.25 vs. 0.52 ± 0.16 vs. 0.50 ± 0.14; p < 0.01).
Conclusion: Statin therapy is associated with sustained improvement of endothelial function up to 10 months. These data support the utility of FMD for the assessment of vascular function in response to lipid‐lowering therapy or other therapeutic interventions in long‐term studies.
Keywords: flow‐mediated vasodilation, statins, brachial artery, ultrasound
Full Text
The Full Text of this article is available as a PDF (39.2 KB).
References
- 1. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801–809 [DOI] [PubMed] [Google Scholar]
- 2. Meredith IT, Yeung AC, Weidinger FF, Anderson TJ, Uehata A, Ryan TJ Jr, Selwyn AP, Ganz P: Role of impaired endothelium‐dependent vasodilation in ischemic manifestations of coronary artery disease. Circulation 1993; 87 (suppl V):V‐56–V‐56 [Google Scholar]
- 3. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P: Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81: 491–497 [DOI] [PubMed] [Google Scholar]
- 4. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE: Non‐invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111–1115 [DOI] [PubMed] [Google Scholar]
- 5. Stroes ESG, Koomans HA, De Bruin TWA, Rabelink TJ: Vascular function in the forearm of hypercholesterolaemic patients off and on lipid‐lowering medication. Lancet 1995; 346: 467–471 [DOI] [PubMed] [Google Scholar]
- 6. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE: Endothelium‐dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24: 1468–1474 [DOI] [PubMed] [Google Scholar]
- 7. Sorensen KE, Celermajer DS, Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield JE: Impairment of endothelium‐dependent dilation is an early event in children with familial hypercholes‐terolemia and is related to the lipoprotein(a) level. J Clin Invest 1994; 93: 50–55 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Lieberman EH, Gerhard MD, Uehata A, Selwyn AP, Ganz P, Yeung AC, Creager MA: Flow‐induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. Am J Cardiol 1996; 78: 1210–1214 [DOI] [PubMed] [Google Scholar]
- 9. Neunteufl T, Katzenschlager R, Hassan A, Klaar U, Schwarzacher S, Glogar D, Bauer P, Weidinger F: Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 1997; 129: 111–118 [DOI] [PubMed] [Google Scholar]
- 10. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP: Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235–1241 [DOI] [PubMed] [Google Scholar]
- 11. Vogel RA, Corretti MC, Plotnick GD: Changes in flow‐mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle‐aged men. Am J Cardiol 1996; 77: 37–40 [DOI] [PubMed] [Google Scholar]
- 12. O'Driscoll G, Green D, Taylor RR: Simvastatin, an HMG‐coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997; 95: 1126–1131 [DOI] [PubMed] [Google Scholar]
- 13. Neunteufl T, Kostner K, Katzenschlager R, Zehetgruber M, Maurer G, Weidinger F: Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men. J Am Coll Cardiol 1998; 32: 711–716 [DOI] [PubMed] [Google Scholar]
- 14. Anderson TJ, Elstein E, Haber H, Charbonneau F: Comparative study of ACE‐inhibition, angiotensin II antagonism, and calcium channel blockade on flow‐mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol 2000; 35: 60–66 [DOI] [PubMed] [Google Scholar]
- 15. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF Jr, Vita JA: Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996; 96: 1107–1113 [DOI] [PubMed] [Google Scholar]
- 16. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults : Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel II). J Am Med Assoc 1993; 269: 3015–3023 [PubMed] [Google Scholar]
- 17. Lekakis J, Papamichael C, Vemmos C, Nanas J, Kontoyannis D, Stamatelopoulos S, Moulopoulos S: Effect of acute cigarette smoking on endothelium‐dependent brachial artery dilatation in healthy individuals. Am J Cardiol 1997; 79: 529–531 [DOI] [PubMed] [Google Scholar]
- 18. Vogel RA, Corretti MC, Plotnick GD: Effect of a single high‐fat meal on endothelial function in healthy subjects. Am J Cardiol 1997; 79: 350–354 [DOI] [PubMed] [Google Scholar]
- 19. Etsuda H, Takase B, Uehata A, Kusano H, Hamabe A, Kuhara R, Akima T, Matsushima Y, Arakawa K, Satomura K, Kurita A, Ohsuzu F: Morning attenuation of endothelium‐dependent, flow‐mediated dilation in healthy young men: Possible connection to morning peak of cardiac events? Clin Cardiol 1999; 22: 417–421 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Laufs U, La Fata V, Plutzky J, Liao JK: Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998; 97: 1129–1135 [DOI] [PubMed] [Google Scholar]
- 21. Dechend R, Fiebeler A, Park JK, Muller DN, Theuer J, Mervaala E, Bieringer M, Gulba D, Dietz R, Luft FC, Haller H: Amelioration of angiotensin II‐induced cardiac injury by a 3‐hydroxy‐3‐methyl‐glutaryl coenzyme a reductase inhibitor. Circulation 2001; 104: 576–581 [DOI] [PubMed] [Google Scholar]
- 22. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuil‐lez C, Luscher TF: Nitric oxide is responsible for flow‐dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91: 1314–1319 [DOI] [PubMed] [Google Scholar]